Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Egile Nagusiak: | Davies, KE, Chamberlain, JS |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Springer Nature
2019
|
Antzeko izenburuak
Antzeko izenburuak
-
Therapeutic approaches to muscular dystrophy.
nork: Goyenvalle, A, et al.
Argitaratua: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
nork: Guiraud, S, et al.
Argitaratua: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
nork: Fairclough, R, et al.
Argitaratua: (2011) -
Progress in therapy for Duchenne muscular dystrophy
nork: Fairclough, R, et al.
Argitaratua: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
nork: Potter, A, et al.
Argitaratua: (2006)